1. Home
  2. IMRN vs BIOT Comparison

IMRN vs BIOT Comparison

Compare IMRN & BIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

N/A

Current Price

$0.88

Market Cap

7.7M

Sector

Health Care

ML Signal

N/A

Logo Instinct Bio Technical Company Holdings Inc. Ordinary Shares

BIOT

Instinct Bio Technical Company Holdings Inc. Ordinary Shares

N/A

Current Price

$0.19

Market Cap

6.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IMRN
BIOT
Founded
1994
2017
Country
Australia
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
6.6M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
IMRN
BIOT
Price
$0.88
$0.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.9K
★ 436.4K
Earning Date
08-28-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.39
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.17
52 Week High
$1.99
$50.00

Technical Indicators

Market Signals
Indicator
IMRN
BIOT
Relative Strength Index (RSI) 32.67 11.64
Support Level $0.73 $0.17
Resistance Level $0.89 $0.50
Average True Range (ATR) 0.07 0.03
MACD -0.00 0.03
Stochastic Oscillator 8.30 12.17

Price Performance

Historical Comparison
IMRN
BIOT

About IMRN Immuron Limited

Immuron Ltd is a commercial- and clinical-stage biopharmaceutical company focused on the development and commercialization of specifically targeted polyclonal antibodies. Its oral polyclonal antibodies offer delivery within the GI tract and can target viruses or bacteria and neutralize toxins at mucosal surfaces. The Company markets Travelan in Australia, an over-the-counter orally administered passive immunotherapeutic product indicated to reduce the risk of traveler's diarrhea and minor gastrointestinal disorders. Its products include Travelan, ProIBS and Protectyn. Its segments are Research and Development and Hyper-immune products, with Hyper-immune products generating maximum revenue. Australia generates maximum revenue.

About BIOT Instinct Bio Technical Company Holdings Inc. Ordinary Shares

Instinct Bio Technical Company Holdings Inc is a Cayman Islands-based vertically integrated group engaged in the research and development, manufacturing, branding, and distribution of stem cells, regenerative medicine, wellness, and beauty as its core areas. Its product portfolio includes stem cell-derived serums and skincare formulations for aesthetic and dermatological applications. The company also develops regenerative products for skin healing, hydration, and elasticity.

Share on Social Networks: